Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro

Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 M^pro

RSC Adv. 2020 Nov 25;10(70):42765. doi: 10.1039/d0ra90120b. eCollection 2020 Nov 23.

¹ Department of Medicinal and Pharmaceutical Chemistry, Global Institute of Pharmaceutical Education and Research Jaspur Road Kashipur 244713 India v.balaramnavar@gmail.com.
² Department of Medical Biotechnology, Yeungnam University Gyeongsan 38541 South Korea.
³ Department of Biology College of Sciences, University of Hail Saudi Arabia.
⁴ Department of Clinical Laboratory Science, College of Applied Medical Sciences, King Khalid University Abha Saudi Arabia.
⁵ Research Center for Advanced Materials Science, King Khalid University Abha Saudi Arabia.
⁶ Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University P.O. Box No. 173 Al-Kharj 11942 Kingdom of Saudi Arabia.
⁷ Department of Pharmacology, College of Medicine, Al Imam Mohammad Ibn Saud Islamic University (IMSIU) Riyadh 13317 Saudi Arabia.

[This corrects the article DOI: 10.1039/D0RA06038K.].